Description
BDI – BioLife Science GmbH operates as a key supplier to the pharmaceutical industry, specialising in the development and supply of high-quality excipients. The company is dedicated to supporting the production of pharmaceuticals through innovative solutions, ensuring that its products meet the stringent demands of the industry.
Services include:
– Production of excipients for pharmaceutical applications
– Chemical and physical characterisation of excipients
– Development of tailored solutions for specific customer needs
– Quality assurance and regulatory support
– Technical consulting and support
BDI – BioLife Science GmbH is committed to advancing the pharmaceutical sector with its comprehensive range of excipients and services. For more information, visit bdi-holding.com.
Contact Information
Related Listings

CDMO Live Americas . October 20-21, Boston 2026
Experience the future of external manufacturing at CDMO Live, Rotterdam.
19-21st Oct 2026

AI + Digital Maturity in Contract Manufacturing 2026
Exclusive research roundtable on Day Zero of CDMO Live Americas 2026, in partnership with MasterControl











